Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pre-Incision | Other | TAP block administration pre-incision |
|
| Post-Incision | Other | TAP block administration post-incision |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TAP Block | Other | the TAP block is a regional anesthesia technique that targets the somatic nerves supplying the anterior abdominal wall. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean change in opioid consumption (MME) from index procedure to 90 days post-op | Opioid dosage quantities will be measured in morphine milligram equivalents (MME) | Up to 90 days post-operatively |
| Change in Pain Scores from index procedure on a numerical rating scale | Patient-reported pain on a scale of 1-10. | 1, 3, 6, 24, 48, and 72 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| 1. Total Opioid Consumption in MME from Surgery to 90 Days Postoperatively | Sum of all opioid use from surgery to 90 days, in MME | From end of surgery to 90 days post-op. |
| Patient Satisfaction Score with Postoperative Pain Management at Discharge |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Cheguevara Afaneh, MD | Contact | +1 646 962 8462 | cha9043@med.cornell.edu | |
| Hasan Ali | Contact | hoa4002@qatar-med.cornell.edu |
| Name | Affiliation | Role |
|---|---|---|
| Cheguevara Afaneh, MD | Weill Medical College of Cornell University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Weill Cornell Medical College - NewYork-Presbyterian Hospital | Recruiting | New York | New York | 10065 | United States |
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)
beginning at 9 months and ending 36 months following article publication
Investigators whose proposed use of the data has been approved by an independent review committee (:learned intermediary:) identifies for this purpose. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without the investigator support other than deposited metadata.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Satisfaction score using a 5-point Likert scale survey before discharge.
| At hospital discharge (within 3-5 days post-op) |
| Use of Non-Opioid Analgesics within 72 Hours | Count of participants receiving non-opioid pain medications (e.g. acetaminophen, NSAIDs) within 72 hours post-op, including amount and type. | From end of surgery to 72 hours post-op |
| Number of Participants with TAP Block-Related Adverse Events | Incidence of adverse events (e.g. local anesthetic toxicity, infection, bleeding) related to TAP block. | From TAP block administration to 90 days post-op. |